Continue to develop and industrialize of immune diagnostic reagents based on genetic recombination technology and monoclonal antibody technology, all of which are exclusive domestic technologies.
We will provide the world’s highest level of diagnostic system to the customer.
A novel coronavirus infection was identified in December 2019, which confirmed as severe acute respiratory syndrome caused by infection with a new Betacoronavirus. The World Health Organization (WHO) named this new corona-virus as “SARS-CoV-2” and the disease as “COVID-19” that has been causing hundreds of thousands of confirmed human infections worldwide.
MDx COVID-19 Ag Rapid Test is a lateral flow immunochromatography assay for the qualitative detection and diagnosis of SARS-CoV-2 in nasopharyngeal swabs, without using viral transport media. This test can be a supplemental diagnostic assay to real-time PCR assay in advanced laboratory for rapid diagnosis of COVID-19 infection. In addition, this rapid test can be utilized in limited facility by operators with minimum training.
A colored band should always be visualized at C line regardless of the results at T line.
If C line is not visualized, it is a no test. The retest is recommended using new Test Device.
| MFDS License No. | Cat No. | Product Name | Quantity |
|---|---|---|---|
| 20-960 | MDX-CVD-22 | MDx COVID-19 Ag Rapid Test | 20 Tests/Box |